Haymarket Media, Inc.
Subscribe Issue Archive Contact Us About Us Advertise Affiliates PRWeek UK PRReport Germany PRWeek Asia
 
PRWeek US
  • Home
  • News
    •  Analysis
    •  In Brief
    •  Sectors
    •  Podcasts
    •  Newsletters
  • Features
    •  Cover Stories
    •  Opinion
    •  Web Exclusives
    •  Roundtables
  • Reports
    •  Agency Excellence Survey
    •  Agency Business Report
    •  Salary Survey
    •  Marketing Management Survey
    •  CEO Survey
    •  Diversity Survey
    •  Cause Survey
    •  Power List
    •  Career Guide
  • Blogs
    •  The Cycle
    •  The Editor's Blog
    •  Page Views
  • Events
    •  PRWeek Awards
    •  Webcasts
    •  Conferences
  • Jobs
  • Directory
  • Subscribe
    •  Customer Service
    •  Newsletters
  • About Us
  • Podcasts
  • Hot Topics:
  • Healthcare
  • Consumer
  • Technology
  • Media
  • Public Affairs
  • Corporate
  • Green
  • 2008 Campaign
Login | Register  
Home > Blogs > The Cycle
The Cycle

NYT looks at drug ad confusion among marketers

Posted April 17, 2009

The New York Times with drug makers, a consumer watchdog group, the FDA, and Google about how a lack of specified rules for Internet marketing conflicts with the print and TV rules that the FDA currently applies to new media.

Fourteen pharmaceutical companies were warned by the FDA earlier this month for failing to include risk information in search ads. The consensus among communications professionals who spoke with PRWeek is that the FDA needs to develop a clear policy for digital communications. Search ads are used, in part, by pharmaceutical companies as part of a reputation management strategy.

The same sentiment was echoed in today’s story.

Mary Ann Belliveau, health industry director at Google, told the NYT that “… the sense in the industry was ‘that the F.D.A. sent letters about ‘you shouldn’t do this, you shouldn’t do that,’ as opposed to issuing clear digital guidelines that the companies should follow.’”

Now, companies will only use “generic-sounding Web addresses that redirect users to the brand’s site,” an allowance only made for pharmaceutical companies, and are questioning the FDA to evaluate the difference in online marketing techniques.

Related Posts
  • New HIV drug is here
    Today the FDA has granted accelerated approval to Pfizer's HIV medicine Selzentry (or maraviroc). Hi...
  • Merck’s Isentress on track
    A FDA advisory panel recommended the approval of Merck's new HIV drug Isentress yesterday. If approv...
  • New drug war
    Expect in the coming weeks and months to see lots of TV commercials from US drug makers and their tr...
  • I was distracted by the smooth jazz
  • More money for online marketing support

Filed under: Advertising, Corporate Reputation, Healthcare, Marketing, New Media, Public Relations, Social Media, Web sites

Tags:FDA,

Dell launches social media solutions site for healthcare IT

Posted April 14, 2009

With technology changes on the horizon for the healthcare industry, Dell launched a social media site to generate ideas and solutions that would improve the improve the “delivery, efficiency, and quality of healthcare using IT,” the company said on April 6.

The site, called IdeaStorm for Healthcare and Life Sciences, is a branch of IdeaStorm, a brainstorming site which was launched in 2007.

Kerry Bridge, head of digital media communications for Dell, told PRWeek that the site is targeted at large healthcare organizations as well as influencers and key stakeholders in the healthcare blogging industry.

“It’s a huge social media community, specifically looking at healthcare IT,” she says. “And these are the people we want to be talking to, share ideas with. Dell would like to be a valuable member of that community.”

Dell plans to promote the site within healthcare social media communities, on its blog and company Web site, and through the newsletters that the sales force distributes.

“It’s definitely a stake in the ground,” she says. “…[to show] that we’re committed to the healthcare industry.

Related Posts
  • Dell selects WPP
    ROUND ROCK, TX: Dell has selected WPP Group to co-create a stand-alone agency that will provide all ...
  • Upcoming webcast
    Our next webcast is with Visible Technologies, who have recruited Aberdeen Group and Dell to speak. ...
  • Pfizer announces acquisition of Wyeth, launches biopharma Web site
    Pfizer, the world's largest drug maker, enhanced its pipeline with the announcement that it will acq...
  • Dell, addendum
  • Healthcare panel focuses on social media, CSR, and drug safety communciations

Filed under: Blogs, Healthcare, Marketing, Social Media, Technology, Web sites

Tags:Dell

Health messages should be tailored to reach men, as well

Posted April 8, 2009

Much has been made about how to communicate with women, especially those who are considered healthcare decision makers, but an April 8 story in The Boston Globe at a look at the way men communicate health news.

The story says: “Men are raised with inhibitions or ‘rules of manhood’ that may keep them out of the healthcare system, Zoske explains. He says that most health messages are expressed in a ‘feminine form.’ The basic public health theme, he says, is, ‘Notice your body, pay attention when something isn’t working well, and seek help when needed.’ But, Zoske says, this statement doesn’t really speak to guys. He points out that men may be deaf to their body’s symptoms because they are brought up to ignore factors such as vulnerability and pain.”

Other key points include engaging men in a dialogue by letting them know that other men have similar symptons or ailments; communicating health messages by framing them in terms of safety, strength, and performance; and using numbers, statistics, and metaphors because men respond to those communications tools.

Related Posts
  • Yang’s messages carry on
    Even though Jerry Yang is gone, the messages he put into place at Yahoo aren’t, according to Brad ...
  • As if Google and Microsoft weren't ubiquitous already, the two giants will soon be entering the one ...
  • Medpedia launches online health encyclopedia
    Medpedia, an anticipated online health encyclopedia, launched this week. Much like Wikipedia, the si...
  • Health groups form FDA Commissioner Coalition
  • Critics question Apple’s strategy

Filed under: Advertising, Consumer, Healthcare, Marketing, Public Relations

Tags:The Boston Globe

Cloned cow milk marketing site, Ben & Jerry’s prank

Posted April 1, 2009

Ben & Jerry’s announced today it was behind the unsettling corporate site, Cyclone Dairy, a company marketing milk from 100% cloned cows. Part April Fool’s Day prank, part educational campaign, the fake site, which went up about two weeks ago, was created to drive awareness about the use of cloned animals in the food supply and advocate Congress create a national registry and tracking system. AOR Cone supported the initiative.

Related Posts
  • Most daunting jobs in PR, an addendum
    News hits that the FDA, via a draft ruling, is saying cloned meat is safe, leading towards approving...
  • Satirists claim some ‘Times’ staffers - who they won’t identify - worked on anti-’Times’ prank
    More details emerged November 13 about the phony issue of The New York Times distributed to commuter...
  • JPMorgan Chase cares about you!
    Last week, The New York Times ran an exclusive about JPMorgan Chase's rebranding campaign, which beg...
  • Welcome Borat!
  • More money for online marketing support

Filed under: Consumer, Food and Beverage, Healthcare, Public Affairs

Tags:Clones, Cone, Milk

Posted March 18, 2009

Clinical trial recruitment firms and the PR firms that offer this service are starting to look at social media as a means to better reach potential patients that may not be aware of certain trials, or that they could qualify for them.

Last week, the Los Angeles Times on the number of clinical trials that are postponed because enrollment numbers have not been met. And a March 10 Newsweek story at the types of social media networks that pharmaceutical companies are tapping into to recruit patients.

While Facebook and Web sites have been two major for pharmaceutical or biotechnology companies to recruit patients, one firm is eying Twitter - specifically because it is already a public forum, unlike a private Facebook page, says Carmen Gonzalez, manager of strategy and communications for Healthcare Communications Group.

“It’s a way to cut through the noise,” she notes.

The clinical trial recruitment firm recently drafted a set of guidelines to provide to clients who are considering Twitter as a part of their strategy.

Related Posts
  • Cedra prepares for official launch of viral drug site
    Cedra Clinical Research, an overnight clinical research company based in Austin, TX, launched getyou...
  • The fight over experimental drugs
    Some thoughts on an interesting piece in today's USA Today. Buried way down in the middle of the pie...
  • Executive search firms change tactics during downturn
    This week, I wrote a news article about executive search firms and how the economic downturn has aff...
  • Meta mention averted

Filed under: Agency-client relationship, Healthcare, Marketing, Public Relations, Social Media, Web sites

Tags:, Healthcare Communications Group,

Medpedia launches online health encyclopedia

Posted February 19, 2009

Medpedia, an anticipated online health encyclopedia, launched this week. Much like Wikipedia, the site is free although Medpedia is edited and written by pre-screened health professionals only.

James Currier, founder of the project, told The New York Times that medicine is one of the least developed areas on the Web but has the chance to be the most transformed by it.

Mark Senak at Eye on FDA notes: “In time, with the right search engine optimization, Medpedia topics will be very high up on the Google search when a person enters in a specific drug name.  When given a choice of learning about the drug from (1) the manufacturer or (2) an objective third party source representing the finest medical schools in the country, patients and physicians are likely to gravitate to the objective resource.”

For drug companies and device makers, the wiki will present its own challenges. Senak says that, for example, pharmaceutical companies who not to get involved will find that their brands are shaped by the medical professionals who edit the companies’ drug and device information. He writes:

“[Medpedia] signifies another leap in the reality and reach of digital media while regulatory bodies around the world continue to pretend like nothing is happening. That leads to the second, which is that brand control, for companies not anticipating, analyzing and strategically responding to digital media developments, is becoming more and more elusive as the brand becomes shaped by digital media participants.”

Related Posts
  • Health groups form FDA Commissioner Coalition
    Health groups, some supported by pharmaceutical companies, are voicing concerns about the appointmen...
  • A dialogue with Constantin Basturea
    I asked Constantin Basturea, director of new-media strategies for social media communications firm C...
  • The number of peanut butter products recalled because of the salmonella outbreak has soared to nearl...
  • Quick links

Filed under: Branding, Consumer, Healthcare, Media, Social Media, Web sites

Tags:, Medpedia

Posted February 12, 2009

YouTube seems to be the social media trend for Big Pharma so far this year. In the past week, both Sanofi-Aventis and AstraZeneca launched channels targeting specific diseases.

Sanofi’s , an unbranded effort that’s part of the “GoInsulin” campaign, personal stories of patients with diabetes and is the pharmaceutical company’s first YouTube venture. It does not mention Lantus, Sanofi’s insulin therapy; instead it offers general information about insulin.

AstraZeneca’s , considered the Symbicort brand channel, stories of patients affected by asthma. The company also launched a microsite, myasthmastory.com, although a spokesperson told PRWeek it is not part of a larger PR campaign for the asthma drug.

Mark Senak at Eye on FDA:

“Both of these efforts are breathtaking in that they appear deliberate attempts to break the stranglehold that regulatory concerns have had on social media in general and YouTube in particular.  They also both go way beyond what anyone has accomplished so far in terms of creativity and style and in an effort to engage patients.”

The two pharma companies join Johnson & Johnson, Abbott Labs, and GlaxoSmithKline in the YouTube space.

Related Posts
  • YouTube opened a channel exclusively for Congress today - sans ads, which keeps it aligned with prev...
  • Meredith and Comcast partner for Video On Demand
    Meredith and Comcast are joining together to launch a family-focused Video On Demand, scheduled to r...
  • YouTube rolled out a new channel that encourages voters to take out their video cameras come electio...
  • Debate 2.0

Filed under: Branding, Consumer, Healthcare, Public Relations, Social Media, Web sites

Tags:Abbott Labs, AstraZeneca, Eye on FDA, GlaxoSmithKline, Johnson & Johnson, Sanofi-Aventis, Symbicort,

Pfizer asking media to rate PR, will disclose physician payments

Posted February 10, 2009

The Pfizer media machine continues, with the news that the pharma giant is conducting interviews with 250 members of the media to see how well the PR team is doing.

From BNET Pharma: “The remainder of the survey covers predictable territory: how well does Pfizer perform in terms of access, providing experts, executives, responding to deadlines, and the comprehensiveness of its web site.” Read more »

Related Posts
  • Pfizer announces acquisition of Wyeth, launches biopharma Web site
    Pfizer, the world's largest drug maker, enhanced its pipeline with the announcement that it will acq...
  • About 41,000 consumer complaints out of nowhere
    On July 23, the Consumer Federation of America issued a press release announcing that over 30,000 co...
  • FDA approval rate down
    Unsurprisingly, the FDA's approval rate for new drugs is down. Here's the interesting quote from the...
  • Happy Birthday
  • New HIV drug is here

Filed under: Corporate Communications, Healthcare, Media, Public Relations, Web sites

Tags:BNET Pharma, Pfizer

GSK, WellPoint, Edelman, Cleveland Clinic get high marks in survey

Posted January 28, 2009

Media Mind just completed its annual survey of healthcare journalists, tallying their thoughts and views on pharmaceutical companies, insurers, agencies, and medical centers.

GlaxoSmithKline, WellPoint, Edelman, and the Cleveland Clinic came up as the top outlets for journalists to work with. Seventy-five top-tier journalists contributed to the survey, conducted from December 2008 to January 2009.

“There’s a lot of similarities with what the media is looking for,” says Tony Plohoros, president of the media relations firm. “They still want access, they still want responsiveness.”

He also noted that more than half of the journalists who reponded reported that more than half of their work is published online, rather than in print.

“We, as communicators, need to educate our clients that [online] is a great place to be,” says Plohoros.

Here’s a Q&A about last year’s survey.

Related Posts
  • How can the entertainment industry earn trust?
    A new survey from global PR firm Edelman found that entertainment industry is the third-least truste...
  • PRWeek readers’ survey
    We have launched a reader's survey. The results will be published in our 10th anniversary issue on N...
  • Salary Survey
    PRWeek's annual Salary Survey polls PR practitioners about their job compensation packages and other...
  • Edelman new media summit
  • Consumer Reports reliability survey shakes things up

Filed under: Healthcare, Journalism 2.0, Media

Tags:Cleveland Clinic, Edelman, GlaxoSmithKline, Media Mind, WellPoint

Pfizer announces acquisition of Wyeth, launches biopharma Web site

Posted January 27, 2009

Pfizer, the world’s largest drug maker, enhanced its pipeline with the announcement that it will Wyeth for $68 billion as part of the largest pharmaceutical deal in the last 10 years.

Branding the acquisition as the world’s premier biopharmaceutical company, Pfizer and Wyeth launched a Web site, which includes podcasts and vodcasts of the companies’ CEOs talking about the acquisition as well as information for patients and consumers, investors, and media.

But, the announcement also came with the that Pfizer would cut its work force by 10% and reduce the number of manufacturing sites while it prepares to lose half of its pharmaceutical revenue stream by 2015, when the patents for Lipitor, Viagra, and other medications expires.

Here’s a link to a video and two podcasts that features Pfizer’s Ray Kerins and Wyeth’s Gwen Fisher talking about social media, CSR, and drug safety communications at a PRWeek healthcare panel that was held in Philadelphia in November.

Related Posts
  • Pfizer asking media to rate PR, will disclose physician payments
    The Pfizer media machine continues, with the news that the pharma giant is conducting interviews wit...
  • Pharmalot blogger announces buyout
    Ed Silverman, editor of Pharmalot, long considered one of the top blogs covering the pharmaceutical ...
  • Healthcare panel focuses on social media, CSR, and drug safety communciations
    On November 6, Erica Iacono and I traveled to Philadelphia to host PRWeek's healthcare roundtable an...
  • Daily Candy comments on Comcast acquisition
  • Helpful press releases

Filed under: Branding, Corporate Communications, Healthcare, Media, Public Relations, Web sites, layoffs

Tags:Pfizer, Wyeth

Next Page »

The Cycle

For both journalists and communicators, the news cycle never ends. At The Cycle, PRWeek’s editorial team offers commentary and viewpoints on how the latest marketing, business, political, and cultural news impact the PR industry.

Tags
AIG Apple Associated Press Baltimore Sun Barack Obama Burson-Marsteller California CBS Chicago Tribune CNN Congress Dell Edelman Editor & Publisher Fleishman-Hillard Hillary Clinton Huffington Post IR John McCain Keith Olbermann Los Angeles Los Angeles Times Marcus Brauchli Mark Penn Microsoft MSNBC News Corp New York Post New York Times NIRI Porter Novelli PRSA PRWeek PRWeek Awards Scott McClellan The New York Times Tribune Co. Wall Street Journal Washington Post Weber Shandwick WPP Yahoo

RECENT POSTS

Studios still beholden to TV spend

Marketing in a recession (or depression)

SAG and AMPTP reach agreement

Highs and lows of marriage

NYT looks at drug ad confusion among marketers



Authors
  • Aarti Shah (88)
  • Alexandra Bruell (79)
  • Beth Krietsch (5)
  • Erica Iacono (13)
  • Frank Washkuch (135)
  • Gideon Fidelzeid (2)
  • Hamilton Nolan (8)
  • Irene Chang (57)
  • Jaimy Lee (36)
  • Keith O'Brien (115)
  • Kimberly Maul (162)
  • Marc Longpre (1)
  • Matthew McGevna (2)
  • Michael Bush (91)
  • Nicole Zerillo (36)
  • Randi Schmelzer (1)
  • Rose Gordon (40)
  • Ted McKenna (90)
  • Tonya Garcia (139)

Archives
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006

Categories
  • 1
  • 2008 Campaign
  • Advertising
  • Agency-client relationship
  • All PRWeek blogs
  • Announcements
  • Arts & Entertainment
  • Automotive
  • Awards
  • Blogs
  • Branding
  • Careers
  • Consumer
  • Corporate Communications
  • Corporate Reputation
  • Crisis Communications
  • CSR
  • Culture
  • Diversity
  • Education
  • Events
  • Financial/IR
  • Food and Beverage
  • Green
  • Guerilla/WOM
  • Healthcare
  • HR
  • Industry/Energy
  • Internal Communications
  • International
  • Journalism 2.0
  • layoffs
  • Lobbying
  • Marketing
  • Measurement/Monitoring
  • Media
  • Miscellaneous
  • Mobile Marketing
  • Multicultural
  • Music
  • New Media
  • Partially there
  • Politics
  • Product Launch
  • PRWeek
  • PRWeek Awards
  • Public Affairs
  • Public Relations
  • Social Media
  • Sports
  • Technology
  • Travel
  • Viral Video
  • Web sites

  • Blogroll

    • WordPress.com
    • WordPress.org

Home | News | Newsletters | Blogs | Directory | PR Jobs | Events | Subscribe | Contact Us | About Us | Editorial Calendar | Reprints | Advertising

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions